Tolerance of growth factor administration for stem cell mobilization in normal donors.

被引：0
|
作者：
Lane, TA [1 ]
Law, P [1 ]
Corringham, RE [1 ]
Mason, J [1 ]
Echon, C [1 ]
Ho, AD [1 ]
机构：
[1] UNIV CALIF SAN DIEGO,BLOOD & MARROW TRANSPLANT PROGRAM,LA JOLLA,CA 92093
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3676 / 3676
页数：1
相关论文
共 50 条
  • [41] Peripheral blood stem cell mobilization from healthy donors
    Ozkan, Melda Comert
    Sahin, Fahri
    Saydam, Guray
    TRANSFUSION AND APHERESIS SCIENCE, 2015, 53 (01) : 13 - 16
  • [42] Stem cell mobilization and collection from patients and healthy donors
    Unal, Ali
    TRANSFUSION AND APHERESIS SCIENCE, 2015, 53 (01) : 1 - 2
  • [43] Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective
    Moussab Damlaj
    Ahmed Alaskar
    Samer Ghazi
    Bader Alahmari
    Ayman Alhejazi
    Mohsen Al-Zahrani
    Bone Marrow Transplantation, 2018, 53 : 1366 - 1368
  • [44] Peripheral Hematopoeitic Stem Cell Mobilization Utilizing Growth Factors in Donors with Sickle Cell Trait is Safe and Effective
    Damlaj, Moussab
    Alaskar, Ahmed
    Ghazi, Samer
    Alahmari, Bader
    Alhejazi, Ayman
    Alzahrani, Mohsen
    BONE MARROW TRANSPLANTATION, 2018, 53 : 754 - 755
  • [45] Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective
    Damlaj, Moussab
    Alaskar, Ahmed
    Ghazi, Samer
    Alahmari, Bader
    Alhejazi, Ayman
    Al-Zahrani, Mohsen
    BONE MARROW TRANSPLANTATION, 2018, 53 (10) : 1366 - 1368
  • [46] One year follow-up of peripheral blood stem cell donors.
    Stroncek, DF
    Smith, J
    Clay, ME
    Jaszcz, W
    McCullough, J
    TRANSFUSION, 1997, 37 (09) : S303 - S303
  • [47] Efficacy of Afternoon Plerixafor Administration for Stem Cell Mobilization
    Elrahi, Cynthia
    Cox, James
    Kamble, Rammurti T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S116 - S117
  • [48] An analysis of ''elderly'' (age >=50 years) allogeneic stem cell pheresis donors.
    Goodnough, LT
    Brown, R
    Adkins, D
    DiPersio, J
    BLOOD, 1995, 86 (10) : 2306 - 2306
  • [49] DECREASING LABOR AND COST OF CALCIUM IN APHERESIS AUTOLOGOUS AND ALLOGENEIC STEM CELL DONORS.
    Mastrovich, Jeannette
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 16 - 17
  • [50] Efficacy of Afternoon Plerixafor Administration for Stem Cell Mobilization
    El Rahi, Cynthia
    Cox, James Eldin
    May, Romelia
    Carrum, George
    Anyadike, Gloria Obi
    Scholoff, Audrey
    Kamble, Rammurti
    CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS, 2018, 11
12345